News

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
If you have questions or concerns about the risk of kidney problems with Zepbound, talk with your ... registry collects information about the safety of certain drugs when used during pregnancy.
Zepbound, a brand-name version of tirzepatide ... which have been riddled with safety concerns but are nonetheless relied on for their relative affordability and accessibility.
The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and ...
The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...
Eli Lilly (NYSE: LLY) is one of the undisputed leaders in developing anti-obesity medicines, with Novo Nordisk (NYSE: NVO) ...
The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in a head-to-head study of the two drugs.